Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia

Season 3 Episode 4  ·  May 17, 2022, 02:30 PM
Headliner
Share
Subscribe

In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.

Share
Subscribe
Next
The Road to Improving Diffuse Large B-Cell Lymphoma Treatment
Top episodes
Individualizing Immunotherapy in Non–Small Cell Lung Cancer
by Treating Together
The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment
by Treating Together
Modern Strategies Improving Immunotherapy in Cancer
by Treating Together